Placebo-Controlled Comparison of Two Different Brands of Modified-Release Oral Dosage Forms Regarding Safety and Efficacy in Children With Attention Deficit Hyperactivity Disorder (ADHD) Aged 6 - 14

This study has been completed.

Study NCT00254878 Information provided by Novartis

First Received: November 15, 2005 Last Updated: December 17, 2007 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	February 2006
Estimated Primary Completion Date:	No date given